---
schema_version: "secwatch.filing_event.v1"
accession: "0001110803-23-000003"
form_type: "8-K"
ticker: "ILMN"
cik: "0001110803"
company_name: "ILLUMINA, INC."
filed_at: "2023-01-11T23:59:59+00:00"
generated_at: "2026-06-20T16:24:49.626975+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "low"
source: SEC EDGAR
---

# Illumina presents preliminary Q4/FY 2022 results at J.P. Morgan conference; no specific figures in filing

## Summary
- Announced preliminary financial results for Q4 and fiscal year ended Jan 1, 2023 during J.P. Morgan Healthcare Conference.
- Filed transcript (Ex-99.1) and non-GAAP reconciliations (Ex-99.2, Ex-99.3) but actual revenue, EPS, or guidance figures not reproduced in the provided text.
- No quantitative details on performance, segment results, or forward guidance are disclosed in the filing excerpts.
- Investors would need to access the full webcast or transcript for the specific financial data referenced.

## SEC filing metadata
- accession: 0001110803-23-000003
- form_type: 8-K
- ticker: ILMN
- cik: 0001110803
- company_name: ILLUMINA, INC.
- filed_at: 2023-01-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: low
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1110803/000111080323000003/0001110803-23-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1110803/000111080323000003/ilmn-20230109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001110803-23-000003
- JSON: https://secwatch.observer/filing/0001110803-23-000003.json
- Plain text: https://secwatch.observer/filing/0001110803-23-000003.txt

## Key facts
- Earnings Releases
  ILLUMINA, INC. reported preliminary financial results for fourth quarter and fiscal year ended January 1, 2023.
  - Period: fourth quarter and fiscal year ended January 1, 2023
  - Result: preliminary results
  source text: On January 9, 2023, Illumina, Inc. (the "Company"), presented at the J.P. Morgan Healthcare Conference in San Francisco, California during which it discussed preliminary financial results for the fourth quarter and fiscal year ended January 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1110803/000111080323000003/0001110803-23-000003-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.